Procurement of an assay to measure severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in human blood samples for the UK Biobank study of seroprevalence of COVID-19
Estimated value
£1.6m
Awarded value
£1.6m
Awarded 04 Jun 2020
Suppliers
1
Lots
1
1 awarded
Published
23 Jun 2020
Deadline 01 Jan 2020
Awarded suppliers· 1 supplier
Awarded 04 Jun 2020 · Contract period 04 Jun 2020 — 03 Jun 2021
Award value
£1.6m